Sumitomo Chemical India FY26 net profit rises 7% to ₹543 crore
Sumitomo Chemical India reported a 7% rise in FY26 net profit to ₹543 crore, with revenue increasing 3% to ₹3,238.3 crore. The board declared a final dividend of ₹1.30 per share and scheduled an earnings call for May 28, 2026.
*this image is generated using AI for illustrative purposes only.
Sumitomo Chemical India has reported a consolidated net profit of ₹543 crore for the financial year ended March 31, 2026, an increase of 7% from ₹506.4 crore in the previous year. Revenue from operations for the year rose 3% to ₹3,238.3 crore, compared to ₹3,148.5 crore in FY25. Profit before tax for the year stood at ₹727.6 crore, up from ₹680.2 crore in the prior year. The Board of Directors has declared a final dividend of ₹1.30 per equity share, subject to shareholder approval, aggregating to ₹648.89 million. The company has scheduled an earnings call with investors and analysts to discuss the financial performance for the quarter and year ended March 31, 2026, on May 28, 2026, at 2:00 pm IST.
The company's standalone net profit for FY26 was ₹543.1 crore, compared to ₹501.9 crore in the previous year. Standalone revenue from operations increased to ₹3,185.8 crore from ₹3,090.4 crore in FY25. The financial results were reviewed by the Audit Committee and approved by the Board on May 26, 2026. An investor presentation for the quarter and year ended March 31, 2026, was submitted to the exchanges on May 27, 2026.
Annual Financial Performance
| Metric (₹ In Crore) | FY26 (Audited) | FY25 (Audited) |
|---|---|---|
| Revenue from operations | 3,238.3 | 3,148.5 |
| Total income | 3,385.0 | 3,268.6 |
| Total expenses | 2,633.5 | 2,588.3 |
| Profit before tax | 727.6 | 680.2 |
| Net profit | 543.0 | 506.4 |
| Earnings per share (₹) | 10.88 | 10.13 |
Q4 Quarterly Performance
Sumitomo Chemical India's quarterly performance also reflected improvement. The company's Q4 EBITDA rose to ₹134.2 crore versus ₹119.6 crore in the same period of the previous year, with the EBITDA margin expanding to 19.6% from 17.6% year-on-year.
| Metric (₹ In Crore) | Q4 Current Year | Q4 Previous Year |
|---|---|---|
| EBITDA | 134.2 | 119.6 |
| EBITDA Margin | 19.6% | 17.6% |
| Consolidated Net Profit | 111.3 | 99.8 |
| Consolidated Revenue | 683.7 | 679.4 |
Segment and Operational Details
Sumitomo Chemical India operates a single reportable segment, agro-chemicals. The company noted that its business is seasonal in nature and performance depends on monsoon and climatic conditions. During the quarter ended December 31, 2025, the company recognised an exceptional item of ₹16.1 crore related to the incremental impact of the new Labour Codes notified by the Government of India.
Board Reconstitution
The Board of Directors has approved the reconstitution of the board effective September 1, 2026. Mr. Mukul Govindji Asher's current and final term as Independent Director and Chairman will be till August 31, 2026. Mr. Chetan Shantilal Shah's current and final term as Managing Director will be till August 31, 2026, following which he is proposed to be appointed as Non-Executive Non-Independent Director. Dr. Suresh Ramachandran is proposed to be appointed as Managing Director with effect from September 1, 2026.
Historical Stock Returns for Sumitomo Chemical
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.54% | -7.17% | -12.27% | -8.55% | -17.92% | +10.70% |
How will the upcoming leadership transition in September 2026 impact the company's strategic direction?
What are the management's growth projections for FY27 given the seasonal dependence on monsoon patterns?
Will the expansion in Q4 EBITDA margins be sustained through the next financial year?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
